StonvexLoading…
StonvexStonvexStonvexCore line items from CQP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $10.76B | $8.70B | $9.66B | $17.20B |
Operating Income | $3.71B | $3.28B | $5.04B | $3.38B |
Net Income | $2.99B | $2.51B | $4.25B | $2.50B |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $17.44B | $17.45B | $18.10B | $19.63B |
Total Liabilities | $17.02B | $17.96B | $18.89B | Not available |
Cash & Equivalents | $182.00M | $270.00M | $575.00M | $904.00M |
Free Cash Flow OCF − CapEx | $2.57B | $2.81B | $2.89B | $3.70B |
Shares Outstanding | Not available | Not available | Not available | Not available |